PD07.04. Prognosis of Patients With Esophageal Squamous Cell Carcinoma Achieved Pathological Complete Regression After Neoadjuvant Immunochemotherapy
Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Pathological complete response (pCR) is an important outcome following neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma (ESCC). However, the long-term prognosis and predictive factors for recurrence in patients who...